Approval · Notice of Compliance 7824 · 2006
SUSTIVA: Notice of Compliance 7824
Issued March 10, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7824
- Date
- March 10, 2006
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph regarding long term safety/efficacy data, and changes to contraindications, warnings and precautions, and drug-drug interactions, including the addition of immune reconstitution syndrome
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUSTIVA | Not yet assigned | — |